Spurgeon, S. E., Coffey, G., Fletcher, L. B., Burke, R., Tyner, J. W., Druker, B. J., . . . Loriaux, M. M. (2013). The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic Leukemia. The American Society for Pharmacology and Experimental Therapeutics.
Citação norma ChicagoSpurgeon, Stephen E., et al. The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic Leukemia. The American Society for Pharmacology and Experimental Therapeutics, 2013.
MLA citiranjeSpurgeon, Stephen E., et al. The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic Leukemia. The American Society for Pharmacology and Experimental Therapeutics, 2013.